Publications
View AllOverall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC
Among patients with previously untreated advanced NSCLC with an <i>EGFR</i> mutation, those who received osimertinib had longer overall survival than those who received a compar...
Institution Info
- Type
- healthcare
- Country
- TH
- Publications
- 2
- Citations
- 5,505
External Links
Identifiers
- ROR
- https://ror.org/04884sy85